Apex as a marker for lung cancer

Details Apex as a marker for lung cancer Apex as a marker for lung cancer

G - Physics

01

N

G01N 33/574 (2006.01) G01N 33/573 (2006.01)

Patent

CA 2681577

The present invention relates to the assessment of lung cancer. It discloses the use of protein APEX in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro using a liquid sample, derived from an individual by measuring APEX in said sample. Measurement of APEX can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.

La présente invention porte sur l'évaluation du cancer du poumon. Elle concerne l'utilisation de la protéine APEX dans l'évaluation du cancer du poumon. Elle porte également sur un procédé pour évaluer un cancer de poumon in vitro à l'aide d'un échantillon liquide provenant d'un sujet, par mesure de l'APEX dans ledit échantillon. La mesure de l'APEX peut, par exemple, être utilisée dans la détection précoce ou dans le suivi de patients ayant un cancer du poumon.

Affiliated with

Also associated with

Rating

Apex as a marker for lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Apex as a marker for lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apex as a marker for lung cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1895830